Entrada Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Entrada Therapeutics Reports Third Quarter 2025 Financial Results
(NASDAQ: TRDA) Delayed: 7.78 +0.51 (7.02%)
Previous Close $7.27    52 Week High
Open $7.49    52 Week Low
Day High $7.79    P/E N/A 
Day Low $7.40    EPS
Volume 241,824